SANTOS DA SILVA JORGE (Chief Executive Officer) sold 4.9% of their position (150K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $2.75M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/14/2026ACC: 0001213900-26-043647
DirectorOfficer· Chief Executive Officer
Since Apr 2022
-150K
Net shares
Net seller
$2.75M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
150K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−98.13K
Price / share
$18.41
Trade value
$1.81M
% of position
3.2%
4/10/2026
3.07M→2.98M
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−51.87K
Price / share
$18.23
Trade value
$945.64K
% of position
1.7%
4/13/2026
2.98M→2.92M
Total
Net shares
−150K
Net value
-$2.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 4/10/2026 | S · Sale | −98.13K | $18.41 | $1.81M | 3.2% | 3.07M | 2.98M |
| Class A ordinary shares, par value $0.0001 per share Direct | 4/13/2026 | S · Sale | −51.87K | $18.23 | $945.64K | 1.7% | 2.98M | 2.92M |
| Total | −150K | -$2.75M | ||||||
Derivative Transactions0
No derivative transactions reported